Spouting Rock Asset Management’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-14,248
Closed -$306K 144
2022
Q2
$306K Buy
14,248
+3,841
+37% +$107K 0.2% 101
2022
Q1
$385K Sell
10,407
-2,715
-21% -$106K 0.32% 52
2021
Q4
$597K Buy
13,122
+1,739
+15% +$90.8K 0.47% 45
2021
Q3
$721K Buy
11,383
+1,334
+13% +$102K 0.36% 82
2021
Q2
$920K Buy
10,049
+1,124
+13% +$89.3K 0.28% 118
2021
Q1
$608K Buy
+8,925
New +$693K 0.19% 142

Other funds holding CDNA

Spouting Rock Asset Management's CDNA Position: Q3 2022 in Review

Spouting Rock Asset Management sold out of CareDx (CDNA) in Q3 2022, closing a stake of 14,248 shares — an estimated $306K sold.

Spouting Rock Asset Management first reported a position in CDNA in Q1 2021 and held it in 6 quarters. The position peaked at $920K in Q2 2021. 182 funds tracked by Wall St. Rank hold CDNA as of Q3 2022.

  • Spouting Rock Asset Management reported no remaining CareDx position as of Q3 2022 after selling out during the quarter.
  • Spouting Rock Asset Management sold 14,248 CareDx shares in Q3 2022, an estimated $306K.
  • Spouting Rock Asset Management first reported a position in CareDx in Q1 2021 and held it in 6 quarters.
  • Spouting Rock Asset Management's CareDx position peaked at $920K in Q2 2021.
  • 182 funds tracked by Wall St. Rank held CareDx as of Q3 2022.

Based on Spouting Rock Asset Management's 13F filing for Q3 2022, filed 8 Nov 2022.